Valuation: Hologic, Inc.

Capitalization 16.75B 14.43B 13.46B 12.52B 23.27B 1,513B 25.01B 154B 60.75B 725B 62.83B 61.53B 2,658B P/E ratio 2026 *
21.6x
P/E ratio 2027 * 18.7x
Enterprise value 16.33B 14.07B 13.12B 12.21B 22.68B 1,475B 24.38B 151B 59.22B 707B 61.24B 59.98B 2,591B EV / Sales 2026 *
3.81x
EV / Sales 2027 * 3.44x
Free-Float
74.01%
Yield 2026 *
-
Yield 2027 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.19%
1 week+0.08%
Current month+0.71%
1 month+0.03%
3 months+13.80%
6 months+16.09%
Current year+0.71%
More quotes
1 week 74.79
Extreme 74.79
75.17
1 month 74.19
Extreme 74.19
75.19
Current year 74.49
Extreme 74.49
75.17
1 year 51.9
Extreme 51.9
75.34
3 years 51.9
Extreme 51.9
87.88
5 years 51.9
Extreme 51.9
87.88
10 years 26.49
Extreme 26.49
87.88
More quotes
Manager TitleAgeSince
Chief Executive Officer 62 2013-12-06
Director of Finance/CFO 56 2018-07-31
Chief Operating Officer 46 2023-12-31
Director TitleAgeSince
Director/Board Member 55 2011-10-31
Chairman 62 2015-06-15
Director/Board Member 71 2017-05-14
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.19%+0.08%+6.87%-6.17% 16.75B
+0.45%+1.22%+12.15%+6.99% 234B
-0.99%-8.60%+0.46%+109.09% 194B
+0.82%+1.83%+0.96%-12.33% 168B
-3.96%-8.74%-5.88%+93.49% 139B
-0.53%+1.06%-8.34%-6.06% 61.18B
+1.67%-0.40%+18.93%+7.89% 48.22B
-0.75%-2.02%+0.98%-7.70% 41.37B
-3.27%-3.79%-1.93%+26.08% 38.86B
+0.46%+5.03%+13.93%+19.53% 37.8B
Average -0.56%-0.83%+3.81%+23.08% 97.87B
Weighted average by Cap. -0.47%-1.77%+3.35%+35.80%
See all sector performances

Financials

2026 *2027 *
Net sales 4.28B 3.69B 3.44B 3.2B 5.95B 387B 6.4B 39.49B 15.53B 185B 16.07B 15.73B 680B 4.51B 3.89B 3.62B 3.37B 6.27B 407B 6.74B 41.58B 16.36B 195B 16.92B 16.57B 716B
Net income 776M 669M 624M 580M 1.08B 70.12B 1.16B 7.16B 2.82B 33.59B 2.91B 2.85B 123B 889M 766M 714M 664M 1.23B 80.25B 1.33B 8.19B 3.22B 38.45B 3.33B 3.26B 141B
Net Debt -423M -365M -340M -316M -588M -38.22B -632M -3.9B -1.53B -18.31B -1.59B -1.55B -67.13B -1.24B -1.07B -994M -925M -1.72B -112B -1.85B -11.4B -4.49B -53.53B -4.64B -4.54B -196B
More financial data * Estimated data
Logo Hologic, Inc.
Hologic, Inc. is the world leader in the design, manufacturing and marketing of diagnostic products, medical imaging systems and surgical products dedicated to women's health. Net sales break down by area of application as follows: - molecular diagnostics (44.2%): rapid diagnostic tests for human diseases detection (sexually transmitted infections, respiratory diseases, viral diseases, infectious diseases, cancers of the cervix and prostate, etc.) and fetal fibronectin; - breast health (37.8%): digital mammography and breast biopsy solutions and systems; - gynecological surgery (15.9%): endometrial ablation devices, minimally invasive intervention systems for the hysteroscopic elimination of targeted intrauterine diseases (including fibroids and polyps). The group also offers fluid management systems for use in hysteroscopic procedures; - bone health (2.1%): bone imaging systems, bone sonometers and osteodensitometers for bone structure and density, and osteoporotic fractures risk assessment. Net sales break down by source of revenue between sales of products (80.8%) and services (19.2%). Net sales are distributed geographically as follows: the United States (75%), Europe (13.2%), Asia-Pacific (6.5%) and others (5.3%).
Employees
7,070
More about the company
Date Price Change Volume
26-01-15 75.02 $ -0.19% 2,359,982
26-01-14 75.16 $ +0.39% 3,490,689
26-01-13 74.87 $ +0.01% 1,511,656
26-01-12 74.86 $ -0.01% 1,516,409
26-01-09 74.87 $ -0.01% 1,898,890

Delayed Quote Nasdaq, January 15, 2026 at 04:00 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
18
Last Close Price
75.16USD
Average target price
76.42USD
Spread / Average Target
+1.67%
Consensus

Quarterly revenue - Rate of surprise